Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt or trimagnesium diisocitrate in hydrate or anhydrate form for preventing and treating high blood pressure and in human and animal medicine

摘要

Use of a pharmaceutical formulation comprising trimagnesium dicitrate salt (2-hydroxypropane-1,2,3-tricarboxylic acid magnesium salt 2:3, Mg 3(C 6H 5O 7) 2) or trimagnesium diisocitrate (1-hydroxypropane 1,2,3-tricarboxylic acid magnesium salt 2:3) as active agents for preventing and treating high blood pressure, is claimed, where the compounds in the formulation are present alone or in combination; and the compounds are formed as hydrate or anhydrate. ACTIVITY : Hypotensive. MECHANISM OF ACTION : None given.